professor abdulhad it is an honor, he was very persistent in the student period, they are extremely intelligent have very good ideas . if he doesn't know something, he says frankly that he doesn't know. he says very frankly that he doesn't know. they have high self-confidence and believe that they should work in their country and for their country. i entered the medical field seriously from the time i was a doctor student in the field of electronic engineering. beshemoth and in the field cell biology, both in the field of pathology and in the field of cancer in general. well, these extensive connections with medical centers in nice doctorate made me get a very good view of the medical field and considering the background i had in the field of electronics and nanotechnology. what is happening in the field of cancer biology that can be translated into electronics? they have a very valid theory . this theory was proposed for the first time in the world. its data was published in nature magazines. it became stronger because on the other hand it made me able the research that i have in mind and the

mohammad abdulhad is here, one of the country's elites in the field of cancer, mr. you from your field of work , what achievement did you have that you decorated the musfa award and what was your contribution to the field of health of our country is at your service. the field in which i was working was receiving new translations of the behavior of cancerous and healthy cells with electronic literature in line with the construction of new diagnosis systems. and for the first time, we added a series of scientific topics that led to the creation of a device named cancer diagnostic probe or cp and a device called metachip. the pro diagnostic ct machine, which we created for the first time in the world, during breast cancer surgery, after the tumor is removed from the patient's body , detects the internal areas of the patient's body that may be cancerous cells. the margin or that border should be cleared, because more than 70-75% of breast cancer recurrences are at the surgical site , and one of the important guidelines is to perform surgery as far as you can while prese